No Data
No Data
JZJ Chain Drugstore Renews License After Reducing Capital
Even With A 32% Surge, Cautious Investors Are Not Rewarding Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Performance Completely
yunnan jianzhijia health-chain (605266.SH): First repurchase of 0.109 million shares.
On September 20th, 健之佳 (605266.SH) announced that on September 20th, 2024, the company repurchased a total of 0.109 million shares of the company through centralized competitive bidding. The repurchased shares accounted for 0.07% of the company's current total share capital. The lowest price of the transaction was 18.21 yuan per share, and the highest price of the transaction was 18.47 yuan per share. The total amount of funds for the repurchase was 1.9992 million yuan.
Yunnan Jianzhijia Health-Chain (605266.SH): One of the actual controlling persons, Lan Xinyue, has increased its shareholding by 0.3739 million yuan in the company.
Jianzhijia (605266.SH) announced on September 13th that Ms. Lan Xinyue, the consistent actor of the actual controller Mr. Lan Bo and Ms. Shuchang, increased the company's shareholding by 20,000 shares through the Shanghai Stock Exchange trading system through centralized bidding on September 13, 2024, accounting for 0.01% of the total share capital of the company, with a transaction amount of approximately 0.3739 million yuan. After this shareholding, Lan Xinyue holds 100,000 shares of the company, accounting for 0.06% of the total share capital of the company.
Declining Stock and Solid Fundamentals: Is The Market Wrong About Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266)?
Yunnan Jianzhijia Health-chain (605266.SH): Shareholder Lan Xinyue increased shareholding of the company's shares by 1.5 million yuan.
Jianzhijia (605266.SH) announced on September 2nd that Mrs. Lan Xinyue, the acting person consistent with the actual controllers Lan Bo and Shuchang, increased their shareholding by 80,000 shares through the Shanghai Stock Exchange trading system on September 2, 2024, through centralized bidding, accounting for 0.05% of the total share capital, with an increase of approximately 1.5 million yuan.
No Data
No Data